Newborn screening involves laboratory tests, diagnostics, and therapeutic measures aimed at pre-symptomatically identifying infants affected by frequent, severe but usually treatable conditions. It has become one of the best accepted preventive pediatric procedures. The screening is a combination of taking a blood sample from infants 2-5 days after birth, testing the sample for various disorders like phenylketonuria, congenital hypothyroidism, and galactosemia, and reporting or recalling babies based on the results within 10 days for optimal health monitoring. Timely sample collection, shipping, laboratory work, and reporting of results is important for newborn screening.